Glaxo to raise stake in Indian unit in £591m deal Consumer Healthcarewhich, which also distributes over-the-counter healthcare products such as Crocin and Sensodyne, had turnover of £380m last year and a compound annual growth rate of 19pc. The deal will be funded by cash. Securities regulations in India require a minimum public shareholding of 25pc for a company to maintain a public listing in the country.